DVONCH JEROME J has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 5000 shares of Sonoma Pharmaceuticals, Inc. ($SNOA) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Sonoma Pharmaceuticals, Inc. | $SNOA | DVONCH JEROME J | Chief Financial Officer | A | Restricted Stock Units | 5000 | $0.00 | 34,391.0000 | 1,730,613 | 17.01% | 0.29% |
| June 19, 2025 | Sonoma Pharmaceuticals, Inc. | $SNOA | DVONCH JEROME J | Chief Financial Officer | A | Restricted Stock Units | 13500 | $0.00 | 25,515.0000 | 1,634,265 | 112.36% | 0.83% |
| Jan. 2, 2025 | Sonoma Pharmaceuticals, Inc. | $SNOA | DVONCH JEROME J | Chief Financial Officer | A | Restricted Stock Units | 10000 | $0.00 | 15,891.0000 | 1,058,447 | 169.75% | 0.94% |
| June 20, 2024 | Sonoma Pharmaceuticals, Inc. | $SNOA | DVONCH JEROME J | Chief Financial Officer | A | Common Stock, $0.0001 par value | 53586 | $0.00 | 84,595.0000 | 780,371 | 172.81% | 6.87% |